Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,631 | 6,937 | 5,561 | 4,707 | 12,373 |
| Marketable Securities | 11,194 | 19,861 | 21,280 | 24,133 | 20,565 |
| Receivables | 14 | 36 | 39 | 115 | 105 |
| TOTAL | $27,928 | $27,095 | $27,209 | $29,412 | $33,197 |
| Non-Current Assets | |||||
| PPE Net | 89 | 96 | 103 | 112 | 120 |
| Other Non-Current Assets | 31 | 31 | 31 | 31 | 31 |
| TOTAL | $120 | $127 | $134 | $142 | $151 |
| Total Assets | $28,048 | $27,222 | $27,343 | $29,554 | $33,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,114 | 854 | 246 | 865 | 989 |
| Accrued Expenses | 1,786 | 1,491 | 1,080 | 707 | 1,596 |
| TOTAL | $2,900 | $2,345 | $1,326 | $1,572 | $2,585 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,900 | $2,345 | $1,326 | $1,572 | $2,585 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,216 | 1,133 | 1,093 | 1,074 | 1,074 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -116,368 | -110,278 | -105,417 | -102,451 | -99,215 |
| Other shareholders' equity | -41 | -47 | -49 | -41 | -35 |
| TOTAL | $25,148 | $24,877 | $26,017 | $27,982 | $30,763 |
| Total Liabilities And Equity | $28,048 | $27,222 | $27,343 | $29,554 | $33,348 |